AIM Biotech offers a modular platform to co-culture multiple cell types in discrete 3D and 2D channels. Organotypic assays with animal model-like complexities using human cells have been developed (eg. immune checkpoint, T-cell killing, angiogenesis, metastasis, cell migration, blood-brain barrier, etc.) for research, drug discovery & diagnostics.
Based on the combination of Nano, Biotech, IT and Cognitive Sciences Aryballe Technologies develops and supplies Innovative technologies, databases, software and devices applied to the identification, measurement and representation of smells and tastes.
Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer.
Biological Dynamics, Inc.
Biological Dynamics, Inc. is a San Diego based molecular diagnostic company with a primary focus on oncology. Biological Dynamics’ novel lab-on-a-chip platform uses the company’s proprietary ACE technology to isolate and analyze cell-free nanoparticles and macromolecules directly from biofluids.
Biond Solutions (BI/OND)
BI/OND aims at providing biologists with customizable Organ-on-Chips (OOCs) built to outperform the limitations of standard in vitro assays. Our young and enthusiastic team is ready to use their expertise in silicon and polymer microfabrication to adapt our versatile platform to your needs.
The company is focused on bringing quantitation to rapid point-of-care testing, allowing earlier and precise treatment that will benefit patients in developing countries and worldwide.
bioSyntagma enables solutions to the big questions of the life sciences at a scale and scope unmatched by any other technology. Our technology is indispensable for advancing scientific knowledge and the successful clinical treatment of cancer, diabetes, neurological disorders, and auto-immune diseases.
Cellesce is developing technology to use cells from cancer biopsy to generate and grow organoids in 3D that can be used to screen available drugs (and combinations) and identify the optimum treatment. This development work builds on advances in microfluidics and ‘organ-on-a-chip’ technology.
CellPly is a life-science company that develops in-vitro diagnostic platforms supporting personalized cancer treatment. Leveraging on a patented microfluidic technology, highly-integrated cell processing and analysis methods are supported and drug testing in the clinical setting is enabled with a high degree of automation and standardization.
CrossLife Technologies Inc.
CrossLife Technologies is a life sciences company founded with the mission of alleviating suffering and improving health through the development and commercialization of innovative molecular diagnostics for infectious diseases and non-communicable diseases.
Daktari Diagnostics is a healthcare solutions company that enables enhanced disease management in both developed and developing countries. Company is developing of a microfluidic point-of-care HCV viral load assay.
Dropletex specializes in manufacturing microfluidic droplet generators for applications in molecular biology, microparticle synthesis, and microorganism studies. The company manufactures easy to use chips that are capable of generating a wide range of droplet size with high monodispersity.
DST specialises in the development of innovative immunodiagnostic products for various health conditions. Company offers services for the development of ELISA kits, Line Immuno Assays (LIAs), multiplexing, lateral flow and microfluidics based tests for laboratory and Point-of-Care (POC) diagnostics.
Enable Injections develops and manufactures devices that allow patient self-administration of high volume/viscosity drugs. The Enable enFuse technology is a discreet body-worn device that provides a comfortable infusion experience allowing the patient to continue with normal daily activities.
Emultech is a high tech company that helps pharmaceutical organizations with more efficient drug delivery, in order to contribute to a better quality of life. We specialize in microsphere development using microencapsulation in microfluidics.
We are a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists’ ability to use synthetic biology on a scale not currently possible.
GeneFluidics develops a fast, accurate, and simple testing system for improving worldwide health. By integrating novel bionano and microfluidic technologies, the company’s revolutionary platform enables complex tests that are normally performed only by skilled technicians in a laboratory to be performed by anyone, anywhere.
Utilizing emulsion microfluidics, GnuBIO has been able to create a scalable DNA sequencing reaction which encompasses all of the steps necessary for DNA sequencing inside of tiny picoliter-sized aqueous drops.
Immuno Technologies, Inc.
Immuno Technologies focuses on applied research for infectious diseases. With our main focus in Lyme disease and Leptospirosis we develop diagnostic assays and prophylactic/ preventive agents (vaccines) to help mitigate the impact of these diseases in human health.
Indee Labs is developing hardware for gene delivery. Our hardware is uniquely positioned for the efficient development and scalable manufacturing of gene-modified cell therapies. Gene delivery via microfluidic vortex shedding enables fast processing of small and large volumes of human primary immune cells.
Inito is a medical technology company building the next generation of portable diagnostic devices that are not just accurate and reliable, but are also smart and easy to use. Our proprietary technology allows a single device to perform dozens of diagnostic tests at home making people happier, healthier and more productive.
Intabio, Inc. develops Blaze system, a bench-top instrument, microfluidic chip, and reagent kit for separation, quantitation, and molecular mass identity analysis. The company also develops a microfluidic platform to provide real-time and direct characterization of intact protein isoforms to identify the specific modification.
We combine bioscience, nanoscience, microchip development, algorithms and engineering to develop and manufacture instrumentation that supports ion channel research and new approaches to disease analysis and individualized treatment modalities.
Karius is a life sciences company focused on conquering infectious diseases through the innovative use of next-generation sequencing to analyze microbial cell-free DNA. The company’s genomics platform uses a combination of machine-learning, proprietary signal processing algorithms, and next-generation sequencing to enable the broad and rapid detection of microbial cell-free DNA through a standard blood draw.
LumaCyte is an advanced research and bioanalytics instrumentation company headquartered in Charlottesville, VA. LumaCyte produces label-free, single cell analysis and sorting instrumentation where the use of antibody or genetic labelling is not required for cellular analysis.
MBio Diagnostics, Inc.
MBio Diagnostics provides rapid, on-the-spot testing solutions for our global commercial partners. Our portable LightDeck® platform delivers panels of lab-quality results in minutes for critical applications in health care, veterinary, food and environmental industries.
It is a limited liability company that commercializes blood related research developed by Dr. Adrienne Minerick at Michigan Technological University. Company is developing microdevice for rapid blood typing without reagents and hematocrit determination.
Mirada Technologies Inc.
Mirada Technologies Inc. develops and sells LiDAR sensor components for autonomous vehicles and advanced driver safety systems to automotive suppliers. Mirada has invented an ultra low cost, high performance laser beam steering technology based on microfluidics.
Miroculus is a hands off sample-to-answer solution for molecular testing. Miroculus delivers assay flexibility and automation capacity in an affordable digital microfluidics platform, which enables seamless workflow integration from novel molecular protocols to data analytics.
Company develops a product that will provide unique opportunity to populations to test their water for safety and health benefits, in locations where good water treatment facilities do not exist.
MouSensor, Inc. is an early-stage biotech company that engineers super sniffer mice to build a live, human nose-on-a-chip with the bold vision to detect, discover and digitize every single smell on this planet; from the fragrances in a perfumer’s palette to the odors associated with diseases such as Parkinson’s.
Nanna Therapeutics has developed a tightly integrated set of proprietary technologies that radically disrupt current methods of creating new medicines. This Totally Integrated Medicines Engine (TIME) has been devised to answer the needs of drug discovery and development scientists utilising the best in 21st century technologies of microfluidics, nanofabrication and artificial intelligence.
Namocell is a Bay Area start-up that manufactures microfluidic instruments for the life sciences market. Namocell’s patented design enables fast yet gentle cell sorting and dispensing of single cells into microtiter plates. The instrument simplifies the cell prep for a number of single cell applications, including cell line development, single cell genomics, monoclonal antibody clone selection, CRISPR, synthetic biology and circulating tumor cells (CTCs) isolation.
NeuroLux aims to provide revolutionary Discovery Tools for Neuroscience. Our cutting edge technology provides the best solution for optogenetic simulation in freely moving animals. NeuroLux’s super lightweight optogenetic devices are fully implantable and adaptable to any enclosure.
Our ADEXUSDx® product line features a lab at your fingertip, using a drop of blood to test for a variety of conditions, illnesses, and diseases with results in a matter of minutes. By eliminating the need to send tests to off-site laboratories, NOW Diagnostics has the potential to dramatically decrease the waiting period to determine test results.
Phase Scientific International Limited
Founded by scientists at the University of California, Los Angeles, Phase Scientific International Limited is a fast-growing biotech startup developing cutting-edge technologies that we believe will change the landscape in diagnostics and healthcare management.
PixCell Medical Technologies
Company develops, produces, and markets portable medical diagnostic products for point of care testing. PixCell’s products are based on its innovative Viscoleastic Focusing (VEF) technology and single-use cartridges that enable rapid, accurate and simple blood sampling and analysis.
Platelet BioGenesis, Inc., a biotech company, produces commercial scale donor-independent human platelets from pluripotent stem cells for clinical application. The company develops a microfluidic bioreactor that is used to generate functional platelets from human stem cell cultures at scale.
POC Medical System, Inc
POC Medical Systems Inc. engages in the development of a breast cancer screening tool for diagnosis. It develops Point-Of-Care testing that is performed near the site of the patient for timely response in patient care.
PolyPico Technologies Ltd.
PolyPico Technologies is commercialising and award winning patented technology utilising acoustic energy for non contact, Ultra Low Volume fluid dispensing utilising a disposable cartridge that avoids cross contamination and cleaning equipment and processes.
Protein Fluidics is commercializing new microfluidic systems for bio-sample analysis in order to accelerate data-driven decisions. We are passionate about providing scientists with the latest technologies to help them create the next generation of therapeutics.
Quanterix is a company that is digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s ultra-sensitive detection solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the role of biomarkers in the continuum of health to disease.
rqmicro AG develops and markets proprietary reagents and innovative instruments for rapid microbiological tests in water and food. rqmicro uses the great potential of microfluidics to deliver a product that allows for a highly efficient separation of target from any sample matrix, using immunomagnetic separation (IMS).
Samplix is a Denmark based company dedicated to providing products for targeted single molecule enrichment of DNA and RNA. The Xdrop technologies are based on advanced microfluidics which in a simple work process partitions millions of molecules in droplets thereby enabling high quality targeted enrichment of large fragments (>100 kb) for subsequent sequencing.
Sandstone Diagnostics, Inc.
Sandstone Diagnostics is a Bay Area consumer health company focused on innovative technologies that empower people to measure and improve important health markers at home. Sandstone’s lead product, Trak, is a home test kit and mobile app that allows men to measure, track, and try to improve their sperm count at home as couple’s are trying to conceive.
Sano Intelligence Inc.
We have created a biometric sensor patch and mobile app that together enable the painless detection of chemical metabolic data. The first application of this technology is continuous glucose sensing.
Shaw Mountain Technology
Shaw Mountain Technology is a small business that specializes in shape memory alloys, particularly the magnetic shape memory alloy Ni-Mn-Ga, and develops various technologies within the fields of sensors, microfluidics, energy harvesters and actuators.
Singularity Sciences Inc.
Singularity Sciences is developing a revolutionary lab-on-a-chip technology for panel-based, low-cost, on-site diagnostics. Our device will be fully patient operated, only require several drops of blood and provide clinically accurate results in minutes.
During the past two years, Stämm has designed a novel bioproduction system that leverages microfluidics, electroporation and robotics to solve the main constraint of the biotech industry: scaling up. We downsized a whole biotech plant into an all-in-one, plug-n-play desktop unit: the Bioprocessor.
Travera is using a breakthrough technology to measure which cancer drugs work against each individual’s unique cancer cells. We are developing a universal biomarker for enabling oncologists to quickly determine which drugs to prescribe based on the actual responses of their patients’ tumor cells to candidate drugs.
We developed a fast and low cost diagnostic and disease surveillance technology for infectious diseases which allow doctors, nurses and community health workers to diagnose diseases directly on the point of care, in less than 15 minutes, without the use of any lab equipment in three simple steps.
As a platform technology, the ClotChip™ sensor from XaTek is agnostic to the cause of the bleeding disorder and is therefore uniquely situated to serve urgent needs of a number of medical different markets. The XaTek device is sensitive to the entire hemostatic process, including platelet disorders.
Xylyx Bio, Inc.
Xylyx Bio specializes in cell-specific biomaterials. Rather than isolated components or synthetic materials, the Company’s suite of extracellular matrix-derived products provide the most physiological cell environment possible in which to create and deliver effective science-based solutions for the benefit of human life and health.
Zephyrus Biosciences, Inc.
Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level. Company is developing microfluidic disposables and instrument for a single-cell western blotting system. Acquired by Bio-Techne.